The lesser known effects of statins

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39024.513218.BE (Published 09 November 2006) Cite this as: BMJ 2006;333:980

Benefits on infectious outcomes may be explained by “healthy user” effect

  1. Reimar W Thomsen, senior research fellow (uxreth@aas.nja.dk)
  1. 1Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg Hospital, DK-9000 Aalborg, Denmark

Statins reduce the risk of vascular events and are also cost effective.1 In recent years, non-randomised studies have linked statins with a list of biologically diverse actions, indicating that statins have pleiotropic effects.2 3 For severe infections—such as pneumonia, sepsis, or bacteraemia—at least six studies have linked statin use with decreased (to one third or less in some reports) risks of severe sepsis or death; this has caused great excitement among infectious disease and intensive care physicians.4 5

In this issue of the BMJ, Majumdar and colleagues report outcomes in 3415 Canadian patients with community acquired pneumonia.6 They found that statins slightly reduced the risk of in-hospital mortality or admission to intensive care (crude relative risk 0.80). However, statin users may be “healthy users,” because younger, healthier, better educated, and socioeconomically more privileged people may be more likely to receive preventive treatments than less privileged frail people.7 After controlling for measures of the “healthy user” effect (including up to date immunisations, quitting smoking, and …

View Full Text

Log in

Log in through your institution


* For online subscription